Literature DB >> 1549208

Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

D J Lange1, W Trojaborg, N Latov, A P Hays, D S Younger, A Uncini, D M Blake, M Hirano, S M Burns, R E Lovelace.   

Abstract

We studied 169 patients with motor neuron disease. Seventeen showed abnormal amplitude reduction of the compound muscle action potential. Ten had focal loss of both amplitude and area across a specific segment (conduction block). Eight of the 10 had slowing of conduction across that segment. Nine were men and had prominent hand involvement. Six had probable or definite upper motor neuron signs. Five of the 10 showed immunologic abnormalities (elevated GM1 antibody titers or paraproteinemia), and eight had had symptoms for more than 4 years. Seven of the 17 patients showed loss of amplitude without corresponding loss of area and focal slowing of conduction (temporal dispersion). Five of the seven were men, five had prominent hand involvement, and five had definite or probable upper motor neuron signs. Two had immunologic abnormalities, and ony one had had symptoms for longer than 4 years. Among 152 patients with no abnormality of conduction, 64% wee men, hands were dominantly involved in 34%, upper motor neuron signs were definite or probable in 72%, and 3% had immunologic abnormalities. None had symptoms for more than 4 years. Because there were so many exceptions, we could not define a unique syndrome by criteria involving conduction block, GM1 antibodies, or lack of upper motor neuron signs. The clinical syndrome associated with multifocal conduction block seemed uniform, however, and patients with conduction block had slower progression if there were no upper motor neuron signs.

Entities:  

Mesh:

Year:  1992        PMID: 1549208     DOI: 10.1212/wnl.42.3.497

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  G Comi; L Roveri
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

3.  The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy.

Authors:  A Ghosh; A Virgincar; R Kennett; M Busby; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

4.  A practical definition of conduction block in IvIg responsive multifocal motor neuropathy.

Authors:  A Ghosh; M Busby; R Kennett; K Mills; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 5.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

Review 6.  Multifocal motor neuropathy.

Authors:  E Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

7.  Response to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy with only sensory symptoms.

Authors:  G W van Dijk; N C Notermans; H Franssen; P L Oey; J H Wokke
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

8.  Multifocal motor neuropathy: clinical and electrophysiological findings.

Authors:  A Jaspert; D Claus; H Grehl; B Neundörfer
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

9.  Inflammatory cells in the peripheral nervous system in motor neuron disease.

Authors:  H Kerkhoff; D Troost; E S Louwerse; M van Dijk; H Veldman; F G Jennekens
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.